FILTER
FILTERED INTERVIEW RESULTS
Paul Hennessey
SENIOR VICE PRESIDENT – OPERATIONS, QUALITY AND TECHNICAL SERVICES, ADVANTICE HEALTH
Advantice Health provides consumer health care products and is focused on building a number of brands.
Dr. Jeffrey Reingold
COO, CONTRACT PHARMACAL CORP
CPC, a full-service contract manufacturer in the US, comments on the current business environment.
Roel Schaapveld
CEO, INTERNA TECHNOLOGIES
InteRNA is a Dutch biotechnology company specializing in the development of RNA therapeutics for the treatment of cancer.
Ravi Udaya Bhaskar
DIRECTOR GENERAL, PHARMEXCIL
India’s Pharmexcil discusses developments in the country’s pharmaceuticals segment.
Anthony Capobianco
FOUNDER AND PRESIDENT, STEMSYNERGY THERAPEUTICS
StemSynergy Therapeutics (SSTI) is a biotechnology company focused on discovering drugs that target biomolecules and cellular processes fundamental to cancer.
Manni Kantipudi & Dr. Ramesh Subramanian
CHIEF EXECUTIVE OFFICER & CHIEF COMMERCIAL OFFICER, GVK BIO
GVK BIO is a global contract research and development organization (CRDO) providing drug discovery and development services to the biopharma industry.
Ahmet Musul
CHAIRMAN, EKOL LOGISTICS
Ekol provides international freight, warehousing, distribution, foreign trade, customs, and supply-chain management services across Europe.
Ed Ikeguchi
CEO, AICURE
AiCure is an AI and advanced data analytics company targeting the health industry.
Dr. Sharvil Patel
MANAGING DIRECTOR, ZYDUS CADILA
Zydus Cadila ranks fourth in the Indian pharmaceutical industry, with a strong global presence in the U.S., Europe, Latin America and South Africa, alongside 25 other emerging markets worldwide.
Dr. Kunal Saxena
MANAGING DIRECTOR, RUSAN PHARMA
Rusan Pharma is a fully integrated pharmaceutical company specializing in the treatment of addiction and pain management.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
MACIG 2026 - Pre-Release
Africa has been attracting more diverse and innovative capital flows over recent years. The US, Europe, the Middle East, Japan, and even India are all crowding in, while China maintains its already well-established presence.
Africa has been attracting more diverse and innovative capital flows over recent years. The US, Europe, the Middle East, Japan, and even India are all crowding in, while China maintains its already well-established presence.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
